NO20005332L - 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding - Google Patents

1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding

Info

Publication number
NO20005332L
NO20005332L NO20005332A NO20005332A NO20005332L NO 20005332 L NO20005332 L NO 20005332L NO 20005332 A NO20005332 A NO 20005332A NO 20005332 A NO20005332 A NO 20005332A NO 20005332 L NO20005332 L NO 20005332L
Authority
NO
Norway
Prior art keywords
glucopyranosyl
composition
mannite
sorbit
gpm
Prior art date
Application number
NO20005332A
Other languages
English (en)
Other versions
NO20005332D0 (no
Inventor
Markwart Kunz
Tillman Doerr
Bodo Fritzsching
Michael Klingeberg
Gunhild Kozianowski
Knut Martin Rapp
Joerg Kowalczyk
Peter J Straeter
Original Assignee
Suedzucker Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suedzucker Ag filed Critical Suedzucker Ag
Publication of NO20005332D0 publication Critical patent/NO20005332D0/no
Publication of NO20005332L publication Critical patent/NO20005332L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelsen av sukkeralkoholblandinger som terapeutisk aktive stoffer.
NO20005332A 1998-04-28 2000-10-23 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding NO20005332L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19818842A DE19818842C1 (de) 1998-04-28 1998-04-28 Erkältungsmittel
US09/175,831 US6139864A (en) 1998-04-28 1998-10-20 Compositions for common colds
PCT/EP1999/002866 WO1999055342A1 (de) 1998-04-28 1999-04-28 Isomalt als wirkstoff enthaltendes erkältungsmittel

Publications (2)

Publication Number Publication Date
NO20005332D0 NO20005332D0 (no) 2000-10-23
NO20005332L true NO20005332L (no) 2000-12-22

Family

ID=26045798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005332A NO20005332L (no) 1998-04-28 2000-10-23 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding

Country Status (19)

Country Link
US (1) US6139864A (no)
EP (1) EP1079839B1 (no)
JP (1) JP5053482B2 (no)
AT (1) ATE275404T1 (no)
AU (1) AU750373B2 (no)
BR (1) BRPI9910024B8 (no)
CA (1) CA2330563A1 (no)
DE (2) DE19818842C1 (no)
DK (1) DK1079839T3 (no)
ES (1) ES2228046T3 (no)
HU (1) HUP0101490A3 (no)
IL (1) IL139318A (no)
MX (1) MXPA00010598A (no)
NO (1) NO20005332L (no)
NZ (1) NZ508371A (no)
PT (1) PT1079839E (no)
RU (1) RU2216329C2 (no)
TR (1) TR200003156T2 (no)
WO (1) WO1999055342A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104055A1 (de) 2001-01-31 2002-08-14 Suedzucker Ag Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren
DE10130298A1 (de) 2001-06-22 2003-01-23 Nutrinova Gmbh Antimikrobiell wirksame Acesulfam-Komplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2004024225A1 (en) * 2002-09-16 2004-03-25 Zicam, Llc. System and method for delivering a composition to the nasal membrane
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
AU2004235732B2 (en) * 2003-04-30 2008-04-03 Zicam, Llc Oral spray to reduce cold symptoms and duration of same
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
DE10328180A1 (de) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Verwendung von Isomalt als Präbiotikum
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP1712139A1 (en) * 2005-04-15 2006-10-18 Cargill Incorporated Sustained energy release compositions
EP2027862B1 (en) * 2006-06-14 2015-04-08 House Wellness Foods Corporation Composition for enhancing immune function comprising zinc and a nigerooligosaccharide
BRPI0811071A2 (pt) * 2007-05-04 2014-09-23 The Procter & Gamble Company Produtos, composições microbicidas, e métodos de uso
DE102008012015A1 (de) 2008-03-01 2009-09-10 Südzucker AG Mannheim/Ochsenfurt Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung
JP5710111B2 (ja) * 2009-07-14 2015-04-30 株式会社ロッテ ラクチトール、マルチトールからなる抗菌剤
JP6039552B2 (ja) 2010-07-01 2016-12-07 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 高産生細胞株を選択するための改良された方法
WO2023105086A1 (en) * 2021-12-10 2023-06-15 Gudiminchi Rama Krishna Use of glycosylated sugar alcohols

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
JPS6131057A (ja) * 1984-07-25 1986-02-13 Fuji Oil Co Ltd フィリング材
JPS6168487A (ja) * 1984-09-12 1986-04-08 Sumitomo Chem Co Ltd カルバモイルアゾール誘導体およびそれを有効成分とする除草剤
DE3826946C1 (no) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
JP2729820B2 (ja) * 1988-12-27 1998-03-18 昭和産業株式会社 免疫賦活剤
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JP3125888B2 (ja) * 1991-03-14 2001-01-22 三菱化学株式会社 エリスリトールを含有する飲料水
RU2061491C1 (ru) * 1993-02-04 1996-06-10 Николай Яковлевич Костеша Способ получения средства, повышающего резистентность организма
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
DE59303142D1 (de) * 1993-05-06 1996-08-08 Suedzucker Ag Süssungsmittel, Verfahren zur Herstellung desselben sowie dessen Verwendung
DE9321600U1 (de) * 1993-05-06 2000-04-06 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt, 68165 Mannheim Süssungsmittel
JP3611131B2 (ja) * 1994-06-30 2005-01-19 カネボウ株式会社 アスコルビン酸含有食品添加用糖衣物
CA2160082C (en) * 1994-10-07 1998-11-10 Melvin E. Klegerman Mixture having antitumor activities
JP3396129B2 (ja) * 1995-06-07 2003-04-14 武田食品工業株式会社 免疫賦活剤
JPH08333261A (ja) * 1995-06-09 1996-12-17 Teika Corp 抗ウイルス・菌剤
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
DE19532396C2 (de) * 1995-09-02 1997-08-21 Suedzucker Ag Zuckerfreie Produkte und Verfahren zu ihrer Herstellung
DE19549825B4 (de) * 1995-09-02 2010-11-04 Südzucker AG Mannheim/Ochsenfurt Zuckerfreie Hartkaramellen
DE19606968C2 (de) * 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel

Also Published As

Publication number Publication date
HUP0101490A3 (en) 2003-07-28
RU2216329C2 (ru) 2003-11-20
JP5053482B2 (ja) 2012-10-17
EP1079839B1 (de) 2004-09-08
CA2330563A1 (en) 1999-11-04
WO1999055342A1 (de) 1999-11-04
NO20005332D0 (no) 2000-10-23
AU4034599A (en) 1999-11-16
BR9910024A (pt) 2000-12-26
HUP0101490A2 (hu) 2001-08-28
DE19818842C1 (de) 2000-01-05
EP1079839A1 (de) 2001-03-07
NZ508371A (en) 2002-09-27
US6139864A (en) 2000-10-31
DE59910457D1 (de) 2004-10-14
BRPI9910024B8 (pt) 2021-05-25
TR200003156T2 (tr) 2001-03-21
PT1079839E (pt) 2005-01-31
AU750373B2 (en) 2002-07-18
ES2228046T3 (es) 2005-04-01
JP2002512966A (ja) 2002-05-08
MXPA00010598A (es) 2002-04-24
DK1079839T3 (da) 2005-01-17
IL139318A (en) 2005-12-18
BRPI9910024B1 (pt) 2015-09-01
ATE275404T1 (de) 2004-09-15
IL139318A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
TW200510375A (en) New compounds
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
CA2350073A1 (en) Ccr5 modulators
HUP0004421A3 (en) Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
CA2292984A1 (en) Ccr5 modulators
DK0886474T4 (da) Karameller indeholdende et södemiddel
TR200002869T2 (tr) İkame edilmiş indolealkonik asitler.
DE69940674D1 (de) Orale verabreichung von adenosin analogen
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
SG26364G (en) 2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
BR9606674B1 (pt) novo derivado de composto de antraciclina e preparação farmacêutica contendo o mesmo.
PT929234E (pt) Comprimidos contendo um edulcorante
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
WO1996021468A3 (en) Chemically modified interferon
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DK0934342T3 (da) Præparat indeholdende chitosan
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
AU2626292A (en) Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
NO903956D0 (no) Sammensetninger som inneholder thymopentin til topisk behandling av hudsykdommer.
IL134600A0 (en) Intermediates for naphthyl and dihydronaphthyl compounds, pharmaceutical compositions containing them and uses thereof as medicaments in the treatment of post-menopausal syndrome
KR960040362A (ko) 방선균주로부터 분리된 다이아네마이신을 유효성분으로 함유하는 항염증작용제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application